secwatch.observer — SEC 8-K summary
======================================

Issuer:     Instil Bio, Inc. (TIL)
CIK:        0001789769
Form:       8-K
Filed at:   2022-09-06T23:59:59+00:00
Accession:  0001789769-22-000077
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Instil Bio appoints Tim Moore as COO, CTO Vijay Chiruvolu resigns
-----------------------------------------------------------------

- Tim Moore appointed COO effective Sept 6, 2022; previously President/COO at PACT Pharma and EVP at Kite.
- Moore receives $565K base salary, $100K signing bonus, 50% target bonus, and 750,000 stock option grant.
- Separately, CTO Vijay Chiruvolu resigned on Sept 2, 2022; terms not disclosed.
- Moore brings cell therapy manufacturing experience, including launch of Yescarta at Kite.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/0001789769-22-000077-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789769/000178976922000077/til-20220902.htm
  HTML page:      https://secwatch.observer/filing/0001789769-22-000077

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer